Literature DB >> 7474122

Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame.

S N Stacey1, D Jordan, P J Snijders, M Mackett, J M Walboomers, J R Arrand.   

Abstract

In this study we investigated the translational capacities of bicistronic and spliced mRNAs originating from the E6 and E7 regions of the high-risk genital human papillomavirus type 16 (HPV-16) and the low-risk HPV-11. For HPV-16 it was found, unexpectedly, that E7 protein could be translated from full-length bicistronic E6-E7 mRNAs. E6*I and E6*II splicing events were not required for E7 synthesis, nor did splicing increase the efficiency of E7 translation significantly. In cells, E7 synthesis from all known naturally occurring mRNA structures was very inefficient compared with that from synthetic monocistronic controls, suggesting that HPV-16 employs translational mechanisms to restrict E7 protein levels. For HPV-11, only RNAs initiated at the P264 promoter, located within the E6 open reading frame, were capable of providing an efficient template for E7 synthesis. P264-initiated mRNAs were as efficient in vivo as monocistronic controls, suggesting that the low-risk HPV-11 does not limit E7 synthesis by translational mechanisms. A detailed analysis of HPV-16 templates by using site-directed mutagenesis showed that the majority of ribosomes which ultimately translate E7 have not reinitiated after translating some or all of the upstream open reading frames. The data support a model in which the failure of 40S ribosomal initiation complexes to recognize the E6 AUG renders them capable of proceeding efficiently to translate E7.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474122      PMCID: PMC189622     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  The eukaryotic translation initiation factor 4E is not modified during the course of vaccinia virus replication.

Authors:  T M Gierman; R M Frederickson; N Sonenberg; D J Pickup
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

Review 2.  5'-terminal cap structure in eucaryotic messenger ribonucleic acids.

Authors:  A K Banerjee
Journal:  Microbiol Rev       Date:  1980-06

3.  General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

Authors:  M Mackett; G L Smith; B Moss
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

4.  The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase.

Authors:  H W Chang; J C Watson; B L Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

5.  Interferon-mediated, double-stranded RNA-dependent protein kinase is inhibited in extracts from vaccinia virus-infected cells.

Authors:  A P Rice; I M Kerr
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

6.  Human papillomavirus type 16 DNA sequence.

Authors:  K Seedorf; G Krämmer; M Dürst; S Suhai; W G Röwekamp
Journal:  Virology       Date:  1985-08       Impact factor: 3.616

7.  Vaccinia rescue of VSV from interferon-induced resistance: reversal of translation block and inhibition of protein kinase activity.

Authors:  P Whitaker-Dowling; J S Youngner
Journal:  Virology       Date:  1983-11       Impact factor: 3.616

8.  Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.

Authors:  D V Heck; C L Yee; P M Howley; K Münger
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

Review 9.  Comparison of initiation of protein synthesis in procaryotes, eucaryotes, and organelles.

Authors:  M Kozak
Journal:  Microbiol Rev       Date:  1983-03

Review 10.  Translational suppression in retroviral gene expression.

Authors:  D L Hatfield; J G Levin; A Rein; S Oroszlan
Journal:  Adv Virus Res       Date:  1992       Impact factor: 9.937

View more
  22 in total

1.  Differential in vitro immortalization capacity of eleven (probable) [corrected] high-risk human papillomavirus types.

Authors:  Denise M Schütze; Peter J F Snijders; Leontien Bosch; Duco Kramer; Chris J L M Meijer; Renske D M Steenbergen
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

2.  Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA.

Authors:  S N Stacey; D Jordan; A J Williamson; M Brown; J H Coote; J R Arrand
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein.

Authors:  Xiaomin Zhao; Daniel Oberg; Margaret Rush; Joanna Fay; Helen Lambkin; Stefan Schwartz
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity.

Authors:  Maria Filippova; Melyssa M Johnson; Marnelli Bautista; Valery Filippov; Nadja Fodor; Sandy S Tungteakkhun; Kadia Williams; Penelope J Duerksen-Hughes
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

5.  Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.

Authors:  Walter G Hubert; Laimonis A Laimins
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation.

Authors:  Shuang Tang; Mingfang Tao; J Philip McCoy; Zhi-Ming Zheng
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 7.  Regulation of human papillomavirus gene expression by splicing and polyadenylation.

Authors:  Cecilia Johansson; Stefan Schwartz
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

Review 8.  Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis.

Authors:  Niladri Ganguly; Suraj P Parihar
Journal:  J Biosci       Date:  2009-03       Impact factor: 1.826

9.  E6/E7 Variants of Human Papillomavirus 16 Associated with Cervical Carcinoma in Women in Southern Mexico.

Authors:  Ramón Antaño-Arias; Oscar Del Moral-Hernández; Julio Ortiz-Ortiz; Luz Del Carmen Alarcón-Romero; Jorge Adán Navor-Hernández; Marco Antonio Leyva-Vázquez; Marco Antonio Jiménez-López; Jorge Organista-Nava; Berenice Illades-Aguiar
Journal:  Pathogens       Date:  2021-06-20

Review 10.  Modulation of apoptotic pathways by human papillomaviruses (HPV): mechanisms and implications for therapy.

Authors:  Chung-Hsiang Yuan; Maria Filippova; Penelope Duerksen-Hughes
Journal:  Viruses       Date:  2012-12-18       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.